STAT3 and neoplasm: Initially, it has been viewed as a factor of malignancy, with the IL-6/JAK/STAT3 signaling path having effects such as anti-apoptosis, angiogenesis, and proliferation [2], while more recent findings have shown that IL-6 also has beneficial roles regarding anti-tumor immunity.